Miravirsen sodium

DRUG2 trials

Sponsors

Santaris Pharma A/S

Conditions

Chronic Hepatitis CHepatitis C

Phase 1

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

CompletedNCT01646489

Santaris Pharma A/SChronic Hepatitis C, Hepatitis C

Start: 2012-06-30End: 2012-09-30Updated: 2012-11-12

Phase 2

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Santaris Pharma A/SHepatitis C

Start: 2012-11-30End: 2014-04-30Target: 10Updated: 2014-01-06